Related Experiment Videos
[Follow-up of perinatal HIV infection]
Insights
This case study follows a 3 1/2-year-old girl with perinatal HIV infection, diagnosed at 6 months. Continuous prophylactic treatment with immunoglobulins and cotrimoxazol is administered.
Area of Science:
- Pediatrics
- Infectious Diseases
- Virology
Background:
- Perinatal Human Immunodeficiency Virus (HIV) infection presents unique clinical challenges in early childhood.
- Understanding the long-term course and management of vertically transmitted HIV is crucial for pediatric care.
Observation:
- A case of a 3 1/2-year-old girl with perinatal HIV infection is detailed.
- The child was diagnosed with HIV at 6 months of age, coinciding with her mother's diagnosis.
- Continuous prophylactic treatment including immunoglobulins and cotrimoxazol has been administered.
Findings:
- The study discusses the pathological findings associated with the child's HIV infection.
- The clinical stage is assessed using the Centers for Disease Control (CDC) classification system.
Implications:
- This case highlights the importance of early diagnosis and continuous management in perinatal HIV infection.
- Findings contribute to the understanding of pediatric HIV clinical progression and treatment efficacy.
Abstract:
The clinical course of a perinatal HIV infection in a 3 1/2-year-old girl is presented. The girl became HIV-positive at the age of 6 months, at about the same time as her mother. She is receiving continuous prophylactic treatment with immunoglobulins and cotrimoxazol. The pathological findings and the stage according to the classification of the Centers for Disease Control are discussed.